Can a navigator help liver cancer patients get better care?
NCT ID NCT06260943
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a program where patients with liver cancer meet with a navigator who helps them connect to medical and community resources. The goal is to understand patient needs and improve access to care and research participation. Adults with hepatocellular carcinoma or other liver cancers can join.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Target Navigation Pilot Program
What this could lead to
If successful, this program could improve access to care and clinical research for liver cancer patients, especially those from underserved communities.
What could go wrong
This is a small, early-stage behavioral study, so results may not apply broadly. It focuses on feasibility and patient experience, not a direct treatment effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AWT020 for Advanced Cancers: Phase 1 Trial NCT06839105
- Liver Fibrosis in HIV-HBV Patients: NCT02344680
- 68Ga-FAPI-46 PET Imaging in Cancer Patients (NCT07118176)
- Contrast Ultrasound vs. MRI for HCC Detection (NCT06184152)
- Deep Multi-Omics Study in Liver Cancer (NCT05516628)
- PRIME-HCC: Ipilimumab & Nivolumab Before Liver S NCT03682276
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact